HCPCS drug code · CMS crosswalk
Reblozyl J-Code / HCPCS Code
In short
Reblozyl is billed under HCPCS J0896 — Injection, luspatercept-aamt, 0.25 mg. One billing unit is 0.25 mg. CMS's crosswalk lists 2 Reblozyl NDCs under this code.
Reference
- J0896
- Injection, luspatercept-aamt, 0.25 mgBilling unit: 0.25 mg
- Labelers
- Celgene Corporation
Medicare Part B payment limit
CMS ASP filePayment limit per unit$43.484
Per0.25 mg
Coinsurance20%
Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Reblozyl units and claim line
Enter the dose given to get the J0896 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Reblozyl NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 59572-0711-01 | J0896 | Celgene Corporation | 1 | 100 |
| 59572-0775-01 | J0896 | Celgene Corporation | 1 | 300 |
Reblozyl: common questions
- What is the J-code for Reblozyl?
- Reblozyl is billed under HCPCS J0896 — Injection, luspatercept-aamt, 0.25 mg. One billing unit is 0.25 mg. CMS's crosswalk lists 2 Reblozyl NDCs under this code.
- How many J0896 billing units are in a package of Reblozyl?
- CMS lists 100 to 300 billing units per package, depending on the NDC, where one unit is 0.25 mg. Units to report are based on the dose given, not the package.
- Is J0896 a CPT code?
- No. J0896 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.